- Home
- / China Medical System
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
China Medical System financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$8.3
2024-10-29
Market Capitalization
$18.8 B
2024-10-29
Revenue
¥8.2 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.4B | 6.1B | 6.9B | 8.3B | 9.2B | 8.0B | 7.5B | 8.2B |
| Cost of goods sold | 1.3B | 1.3B | 1.6B | 1.9B | 1.9B | 1.7B | 1.8B | 2.1B |
| Gross profit | 4.1B | 4.8B | 5.4B | 6.5B | 7.4B | 6.4B | 5.8B | 6.2B |
| Gross profit margin, % | 76.0% | 79.0% | 77.6% | 78.3% | 80.4% | 80.2% | 77.2% | 75.5% |
| Operating expense total | 1.9B | 2.2B | 2.4B | 3.1B | 3.5B | 3.4B | 3.8B | 4.3B |
| Depreciation and amortization | 199.0M | 209.7M | 435.9M | 239.8M | 287.2M | 401.1M | 259.2M | 266.9M |
| EBITDA | 2.3B | 2.7B | 3.2B | 3.5B | 3.9B | 3.3B | 2.3B | 2.2B |
| EBITDA margin, % | 42.3% | 44.9% | 45.7% | 42.1% | 43.0% | 41.7% | 31.2% | 26.2% |
| EBIT | 2.1B | 2.5B | 2.7B | 3.3B | 3.6B | 2.9B | 2.1B | 1.9B |
| EBIT margin, % | 38.6% | 41.4% | 39.4% | 39.3% | 39.8% | 36.6% | 27.7% | 22.8% |
| Interest income | 26.1M | 42.0M | 61.0M | 81.9M | 105.5M | 146.5M | 126.3M | 82.3M |
| Interest expense | 71.9M | 56.3M | 27.5M | 28.3M | 49.1M | 46.3M | 38.6M | 20.3M |
| Pre tax profit | 2.0B | 2.5B | 2.8B | 3.5B | 3.8B | 2.9B | 2.0B | 2.1B |
| Income tax expense | 161.8M | 532.0M | 260.4M | 431.3M | 486.7M | 489.3M | 397.2M | 659.8M |
| Net Income | 1.8B | 2.0B | 2.6B | 3.0B | 3.3B | 2.4B | 1.6B | 1.4B |